America's Best Nonprofits
  1. Home
  2. Disease & Disorders
  3. New York, NY
  4. Myelodysplastic Syndromes Foundation

Myelodysplastic Syndromes Foundation

Myelodysplastic Syndromes Foundation is ranked #41 of 51 disease & disorders organizations in New York, NY, with an America's Best Score of 65 out of 100, based on its 2025 Form 990.

  • New York, NY
  • Tax-exempt since 2000
  • EIN: 22-3283911
mds-foundation.org ProPublica Charity Navigator
Is this your organization? Claim it Tax filings by year Nominate
65OF 100 #41 of 51 in New York ranked disease & disorders organizations How this score is calculated

Organization summary

Myelodysplastic Syndromes Foundation is a 501(c)(3) organization, classified under Disease & Disorders (NTEE G30). Contributions are tax-deductible.

228 Park Ave S Pmb 118983, New York, NY 10003-0103

Among the 85 scored disease & disorders organizations in New York, Myelodysplastic Syndromes Foundation holds 9.6 months of operating reserves (peer median 11.2 months), runs a typical yearly deficit of 27.4% (peers: surplus of 0.8%), and has grown spending 11.8% a year (peers: grown spending 6.1% a year).

In fiscal year 2025 it reported $1,859,509 in revenue and $3,034,024 in expenses, with contributions making up 98.3% of revenue.

Work here? Claim this profile to add your mission, programs and logo.

What it does

From its own Form 990, as filed with the IRS

Mission · 2025 Form 990

The mds foundation is a global nonprofit dedicated to improving the lives of patients with myelodysplastic syndromes (mds) through patient support, education, advocacy, research, and collaboration to advance better care and outcomes worldwide.

Largest programs · fiscal year 2025

  • The mds foundation advocates on behalf of individuals affected by myelodysplastic syndromes (mds), a rare and complex blood cancer. Through education, awareness, and patient engagement, we empower patients and caregivers to make informed healthcare decisions and access appropriate care.we work with healthcare professionals, researchers, and industry stakeholders to ensure the patient voice is repr… Read more

    The mds foundation advocates on behalf of individuals affected by myelodysplastic syndromes (mds), a rare and complex blood cancer. Through education, awareness, and patient engagement, we empower patients and caregivers to make informed healthcare decisions and access appropriate care.we work with healthcare professionals, researchers, and industry stakeholders to ensure the patient voice is represented in treatment development, policy discussions, and clinical guidelines. We provide multilingual educational materials, patient navigation services, public awareness campaigns, and referrals to mds centers of excellence around the world.

    $1,464,845 spent · 71.4% of program spending
  • Educational symposia and a bi-annual conference are conducted in partnership with several societies and associations, including the American society of hematology and the oncology nursing society. In addition, the foundation hosts its own professional educational programs designed to advance the understanding of myelodysplastic syndromes (mds), improve the quality of patient care, and support the… Read more

    Educational symposia and a bi-annual conference are conducted in partnership with several societies and associations, including the American society of hematology and the oncology nursing society. In addition, the foundation hosts its own professional educational programs designed to advance the understanding of myelodysplastic syndromes (mds), improve the quality of patient care, and support the continuing education of healthcare professionals. These informative and interactive programs are aimed at hematologists, oncology nurses, hematology fellows, pharmacists working with mds patients, and other allied health professionals involved in the care and treatment of individuals with mds.

    $269,674 spent · 13.1% of program spending
  • The mds foundation supports and advances scientific research in myelodysplastic syndromes (mds) through its young investigator research program. The foundation invites early-career investigators to submit proposals focused on basic science or clinical research related to the causes, epidemiology, molecular biology, cytogenetics, morphology, prognosis, and management of mds.in addition to funding i… Read more

    The mds foundation supports and advances scientific research in myelodysplastic syndromes (mds) through its young investigator research program. The foundation invites early-career investigators to submit proposals focused on basic science or clinical research related to the causes, epidemiology, molecular biology, cytogenetics, morphology, prognosis, and management of mds.in addition to funding individual research, the foundation convenes international working groups composed of leading scientists and physicians to collaboratively improve diagnostic standards, prognostic tools, and treatment strategies.

    $316,650 spent · 15.4% of program spending

Where each dollar went · fiscal year 2025

Of every dollar it spent, 68¢ went to programs, 15¢ to management and 17¢ to fundraising.

  • Programs $2,051,169
  • Management $453,393
  • Fundraising $529,462

In the organization's own words to the IRS, shown for context. None of this affects the America's Best Score, and a Form 990 describes programs without measuring their results.

America's Best Score

Free assessmentMethodology
Score65 / 100
Rank in New York#41 of 51
DesignationRanked

Score breakdown

MeasureThis organizationPoints
Operating reserves9.6 mo; 7.2 mo in cash6.6 / 25
Financial balance (median margin)−27.4%5 / 20
Transparency5 full 990s, latest TY202520 / 20
Program growth+11.8% / yr13.4 / 15
Track record26 years10 / 10
Debt load8.0% of assets10 / 10
Total65 → 65
Spending on programs
Not scored; America's Best needs 65%+
68%Meets

Compared with New York peers

MeasureThis organizationPeer median
Operating reserves9.6 mo11.2 mo
Typical margin−27.4%+0.8%
Spending growth+11.8% / yr+6.1% / yr
Debt load8.0%7.4%

Peers: the 85 New York disease & disorders organizations with a score, ranked or below the bar.

Tax filings by year

Financial data extracted from the Form 990 the organization filed with the IRS for each fiscal year. Revenue lines can exceed 100% when other items, such as fundraising event costs, are netted against total revenue.

Revenue$1,859,509Fiscal year 20252021: $4,660,61620212022: $2,521,37520222023: $2,562,80620232024: $2,002,12620242025: $1,859,5092025
Expenses$3,034,024Fiscal year 20252021: $2,815,78620212022: $2,174,15920222023: $3,312,84820232024: $2,953,86820242025: $3,034,0242025
Total assets$2,623,801Fiscal year 20252021: $5,238,32720212022: $5,422,22620222023: $5,146,33920232024: $3,847,11220242025: $2,623,8012025
Total liabilities$208,943Fiscal year 20252021: $445,72820212022: $281,33520222023: $754,61420232024: $257,73920242025: $208,9432025
Fiscal year ending December 2025
Revenue$1,859,509
Expenses$3,034,024
Net income−$1,174,515
Net assets$2,414,858

Notable sources of revenue

Percent of total revenue
Contributions$1,828,816
Program services$0
Investment income$27,075
Other (net)$3,618

Assets / debt

Total assets$2,623,801
Total liabilities$208,943
Net assets$2,414,858

Compensation

Not in our extract for this year.

Fiscal year ending December 2024
Revenue$2,002,126
Expenses$2,953,868
Net income−$951,742
Net assets$3,589,373

Notable sources of revenue

Percent of total revenue
Contributions$1,948,899
Program services$0
Investment income$3,563
Other (net)$49,664

Assets / debt

Total assets$3,847,112
Total liabilities$257,739
Net assets$3,589,373

Compensation

Not in our extract for this year.

Fiscal year ending December 2023
Revenue$2,562,806
Expenses$3,312,848
Net income−$750,042
Net assets$4,391,725

Notable sources of revenue

Percent of total revenue
Contributions$1,558,359
Program services$972,104
Investment income$32,321
Other (net)$22

Assets / debt

Total assets$5,146,339
Total liabilities$754,614
Net assets$4,391,725

Compensation

Not in our extract for this year.

Fiscal year ending December 2022
Revenue$2,521,375
Expenses$2,174,159
Net income$347,216
Net assets$5,140,891

Notable sources of revenue

Percent of total revenue
Contributions$2,618,926
Program services$405,541
Investment income$8,487
Other (net)−$511,579

Assets / debt

Total assets$5,422,226
Total liabilities$281,335
Net assets$5,140,891

Compensation

Officers and key employees$147,110
Share of expenses6.8%
Fiscal year ending December 2021
Revenue$4,660,616
Expenses$2,815,786
Net income$1,844,830
Net assets$4,792,599

Notable sources of revenue

Percent of total revenue
Contributions$3,830,988
Program services$1,076,737
Investment income$2,252
Other (net)−$249,361

Assets / debt

Total assets$5,238,327
Total liabilities$445,728
Net assets$4,792,599

Compensation

Officers and key employees$198,251
Share of expenses7.0%

About this data

Figures come from IRS Form 990 filings, through the IRS Exempt Organizations Business Master File (2026-11-09) and e-filed returns. Form 990 data typically lags 12–24 months behind an organization's fiscal year. Found an error?